DETECTION OF INTRACELLULAR LIPOCORTIN-1 IN HUMAN-LEUKOCYTE SUBSETS

被引:61
作者
MORAND, EF [1 ]
HUTCHINSON, P [1 ]
HARGREAVES, A [1 ]
GOULDING, NJ [1 ]
BOYCE, NW [1 ]
HOLDSWORTH, SR [1 ]
机构
[1] BATH INST RHEUMAT DIS,INFLAMMAT RES GRP,BATH,AVON,ENGLAND
来源
CLINICAL IMMUNOLOGY AND IMMUNOPATHOLOGY | 1995年 / 76卷 / 02期
关键词
D O I
10.1006/clin.1995.1115
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Lipocortin 1, a putative mediator of the antiinflammatory actions of glucocorticoids, is present intracellularly in a variety of tissues including human peripheral blood leukocytes. We investigated the presence of lipocortin 1 in human leukocyte subsets using permeabilization flow cytometry. Constitutive lipocortin 1 was detected in U937 myelomonocytic leukemia cells, and lipocortin 1 was increased by treatment with PMA or PMA + IFN-gamma (P < 0.05) but not by dexamethasone. Lipocortin 1 was present in all leukocyte subsets except B lymphocytes (CD19/20(+), P < 0.001). Lipocortin 1 content was maximal in monocytes and polymorphonuclear neutrophils and least in lymphocytes (P < 0.001). Monocyte lipocortin 1 was strongly associated with surface expression of CD14 and HLA-DR. Among non-B lymphocytes, a range of lipocortin 1 fluorescence was observed. Lipocortin 1 fluorescence was greatest in natural killer cells (CD56+, P < 0.001) and CD57(+) cells, but T cell subset markers did not otherwise discriminate variations in lipocortin 1. Induction of lymphocyte proliferation by PHA, anti-CD3, Con A, superantigen, and SAC was not associated with significant shifts in lipocortin 1 content. Dexamethasone (10(-10)-10(-6) M) did not induce increases in PB leukocyte lipocortin 1. We conclude that lipocortin 1 content in human leukocytes varies significantly among phenotypic subsets. This has significance for the investigation of inflammatory disease where certain cell types predominate. (C) 1995 academic Press, Inc.
引用
收藏
页码:195 / 202
页数:8
相关论文
共 48 条
[1]   INHIBITION OF HUMAN SKIN PHOSPHOLIPASE-A(2) BY LIPOCORTINS IS AN INDIRECT EFFECT OF SUBSTRATE LIPOCORTIN INTERACTION [J].
BASTIAN, BC ;
SELLERT, C ;
SEEKAMP, A ;
ROMISCH, J ;
PAQUES, EP ;
BROCKER, EB .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1993, 101 (03) :359-363
[2]   MACROCORTIN - A POLYPEPTIDE CAUSING THE ANTI-PHOSPHOLIPASE EFFECT OF GLUCOCORTICOIDS [J].
BLACKWELL, GJ ;
CARNUCCIO, R ;
DIROSA, M ;
FLOWER, RJ ;
PARENTE, L ;
PERSICO, P .
NATURE, 1980, 287 (5778) :147-149
[3]   LIPOCORTIN-1 FRAGMENT MODIFIES PYROGENIC ACTIONS OF CYTOKINES IN RATS [J].
CAREY, F ;
FORDER, R ;
EDGE, MD ;
GREENE, AR ;
HORAN, MA ;
STRIJBOS, PJLM ;
ROTHWELL, NJ .
AMERICAN JOURNAL OF PHYSIOLOGY, 1990, 259 (02) :R266-R269
[4]   DEFECTIVE HYPOTHALAMIC RESPONSE TO IMMUNE AND INFLAMMATORY STIMULI IN PATIENTS WITH RHEUMATOID-ARTHRITIS [J].
CHIKANZA, IC ;
PETROU, P ;
KINGSLEY, G ;
CHROUSOS, G ;
PANAYI, GS .
ARTHRITIS AND RHEUMATISM, 1992, 35 (11) :1281-1288
[5]  
CHRISTMAS P, 1991, J BIOL CHEM, V266, P2499
[6]   ANTIINFLAMMATORY ACTIONS OF AN N-TERMINAL PEPTIDE FROM HUMAN LIPOCORTIN-1 [J].
CIRINO, G ;
CICALA, C ;
SORRENTINO, L ;
CILIBERTO, G ;
ARPAIA, G ;
PERRETTI, M ;
FLOWER, RJ .
BRITISH JOURNAL OF PHARMACOLOGY, 1993, 108 (03) :573-574
[7]   HUMAN RECOMBINANT LIPOCORTIN-1 HAS ACUTE LOCAL ANTI-INFLAMMATORY PROPERTIES IN THE RAT PAW EDEMA TEST [J].
CIRINO, G ;
PEERS, SH ;
FLOWER, RJ ;
BROWNING, JL ;
PEPINSKY, RB .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1989, 86 (09) :3428-3432
[8]  
DAVIDSON FF, 1987, J BIOL CHEM, V262, P1698
[9]   MACROPHAGE-SPECIFIC EICOSANOID SYNTHESIS INHIBITION AND LIPOCORTIN-1 INDUCTION BY GLUCOCORTICOIDS [J].
DECATERINA, R ;
SICARI, R ;
GIANNESSI, D ;
PAGGIARO, PL ;
PAOLETTI, P ;
LAZZERINI, G ;
BERNINI, W ;
SOLITO, E ;
PARENTE, L .
JOURNAL OF APPLIED PHYSIOLOGY, 1993, 75 (06) :2368-2375
[10]  
DIXEY J, 1993, BR J RHEUMATOL S1, V32, P38